94 related articles for article (PubMed ID: 14599679)
21. Adenoviral delivery of recombinant DNA into transgenic mice bearing hepatocellular carcinomas.
Bao JJ; Zhang WW; Kuo MT
Hum Gene Ther; 1996 Feb; 7(3):355-65. PubMed ID: 8835222
[TBL] [Abstract][Full Text] [Related]
22. A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients.
Yun Z; Lewensohn-Fuchs I; Ljungman P; Ringholm L; Jonsson J; Albert J
J Virol Methods; 2003 Jun; 110(1):73-9. PubMed ID: 12757923
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a human adenovirus viral load assay using the Altona RealStar® PCR test.
Rennert H; Ramrattan G; Chen Z; McIntire P; Michaeel A; Khazanova A; Jenkins SG; Sipley J
Diagn Microbiol Infect Dis; 2018 Apr; 90(4):257-263. PubMed ID: 29433999
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
25. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
[TBL] [Abstract][Full Text] [Related]
26. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.
Clayman GL; el-Naggar AK; Roth JA; Zhang WW; Goepfert H; Taylor DL; Liu TJ
Cancer Res; 1995 Jan; 55(1):1-6. PubMed ID: 7805018
[TBL] [Abstract][Full Text] [Related]
27. Gene therapy for bladder cancer using adenoviral vector.
Wada Y; Gotoh A; Shirakawa T; Hamada K; Kamidono S
Mol Urol; 2001; 5(2):47-52. PubMed ID: 11690547
[TBL] [Abstract][Full Text] [Related]
28. In vivo recombinant adenovirus-mediated p53 gene therapy in a syngeneic rat model for colorectal cancer.
Baek JH; Agarwal ML; Tubbs RR; Vladisavljevic A; Tomita H; Bukowski RM; Milsom JW; Kim JM; Kwak JY
J Korean Med Sci; 2004 Dec; 19(6):834-41. PubMed ID: 15608394
[TBL] [Abstract][Full Text] [Related]
29. A combined lymphokine-activated killer (LAK) cell immunotherapy and adenovirus-p53 gene therapy for head and neck squamous cell carcinoma.
Saito H; Ando S; Morishita N; Lee KM; Dator D; Dy D; Shigemura K; Adhim Z; Nibu K; Fujisawa M; Shirakawa T
Anticancer Res; 2014 Jul; 34(7):3365-70. PubMed ID: 24982341
[TBL] [Abstract][Full Text] [Related]
30. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer.
Wills KN; Maneval DC; Menzel P; Harris MP; Sutjipto S; Vaillancourt MT; Huang WM; Johnson DE; Anderson SC; Wen SF
Hum Gene Ther; 1994 Sep; 5(9):1079-88. PubMed ID: 7833367
[TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus quantification in plasma by an automated real-time PCR assay.
Yerly S; Perrin L; Van Delden C; Schaffer S; Thamm S; Wunderli W; Kaiser L
J Clin Virol; 2007 Apr; 38(4):298-303. PubMed ID: 17321200
[TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of a laboratory-developed real-time PCR assay and RealStar® Adenovirus PCR Kit for quantitative detection of human adenovirus.
Wong SSY; Yip CCY; Sridhar S; Leung KH; Cheng AKW; Fung AMY; Lam HY; Chan KH; Chan JFW; Cheng VCC; Tang BSF; Yuen KY
Virol J; 2018 Sep; 15(1):149. PubMed ID: 30261891
[TBL] [Abstract][Full Text] [Related]
33. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
34. Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer model.
Miyake H; Hara I; Hara S; Arakawa S; Kamidono S
Urology; 2000 Aug; 56(2):332-6. PubMed ID: 10925118
[TBL] [Abstract][Full Text] [Related]
35. A triplex quantitative real-time PCR assay for differential detection of human adenovirus serotypes 2, 3 and 7.
Qiu FZ; Shen XX; Zhao MC; Zhao L; Duan SX; Chen C; Qi JJ; Li GX; Wang L; Feng ZS; Ma XJ
Virol J; 2018 May; 15(1):81. PubMed ID: 29716642
[TBL] [Abstract][Full Text] [Related]
36. A simple and sensitive method for detecting adenovirus in serum and urine.
Henderson YC; Liu TJ; Clayman GL
J Virol Methods; 1998 Mar; 71(1):51-6. PubMed ID: 9628221
[TBL] [Abstract][Full Text] [Related]
37. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
Parker LP; Wolf JK; Price JE
Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
Weinrib L; Li JH; Donovan J; Huang D; Liu FF
Cancer Gene Ther; 2001 May; 8(5):352-60. PubMed ID: 11477455
[TBL] [Abstract][Full Text] [Related]
39. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
[TBL] [Abstract][Full Text] [Related]
40. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer.
Eastham JA; Hall SJ; Sehgal I; Wang J; Timme TL; Yang G; Connell-Crowley L; Elledge SJ; Zhang WW; Harper JW
Cancer Res; 1995 Nov; 55(22):5151-5. PubMed ID: 7585563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
